News
The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...
Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.
Explore cutting-edge methods for detecting alcohol biomarkers and drugs of abuse using alternative sample matrices.
Explore how LC-MS technologies are transforming forensic and clinical toxicology by enabling comprehensive compound detection ...
The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...
Atara Biotherapeutics said a clinical hold on its new drug applications for its Ebvallo tabelecleucel program to treat Epstein-Barr virus by has been lifted by the Food and Drug Administration. The ...
Optimi Health Corp, a manufacturer of GMP-certified MDMA and psilocybin, has received its U.S. FDA Establishment Identifier ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for milsaperidone (Bysanti™) for the treatment of acute ...
For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
1d
Pharmaceutical Technology on MSNFDA accepts Novo Nordisk’s NDA submission for weight management therapyThe US Food and Drug Administration (FDA) has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results